Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4562 ARTÍCULOS , VIENDO DEL 3166 AL 3180

The Pioneering and Unknown Stereotactic Approach of Roeder and Orthner from Göttingen. Part II: Long-Term Outcome and Postmortem Analysis of Bilateral Pallidotomy in the Pre-Levodopa Era

Hamel W, Köppen JA, Müller D, Hariz M, Moll CKE, Krack P.

Stereotact Funct Neurosurg. 2018;96(6):353-363. doi: 10.1159/000495412. Epub 2019 Jan 16.

[Molecular mechanisms of genistein action in the light of therapies for genetic and immunological diseases]

Węgrzyn G, Pierzynowska K, Podlacha M, Brokowska J, Gaffke L, Mantej J, Cyske Z, Rintz E, Osiadły M, Bartkowski M, Puchalski M, Grabski M, Pierzynowski M, Pankanin D, Piotrowska E, Tukaj S.

Postepy Biochem. 2018 Dec 29;64(4):262-276. doi: 10.18388/pb.2018_140.

Clinical and neuroimaging spectrum of hyperglycemia-associated chorea-ballism: systematic review and exploratory analysis of case reports

Gómez-Ochoa SA, Espín-Chico BB, Pinilla-Monsalve GD, Kaas BM, Téllez-Mosquera LE.

Funct Neurol. 2018 Oct/Dec;33(4):175-187.

An Unusual and Intriguing Presentation of Sydenham's Chorea

Mehta S, Goyal MK, Kilbane C, Kumar R, Lal V.

Tremor Other Hyperkinet Mov (N Y). 2018 Oct 9;8:593. doi: 10.7916/D8VM5W0N. eCollection 2018.

New directions in therapeutics for Huntington disease

Potkin KT, Potkin SG.

Future Neurol. 2018 May;13(2):101-121. doi: 10.2217/fnl-2017-0035. Epub 2018 May 29.

A Case of McLeod Syndrome with A Novel XK Missense Mutation

Komiya H, Takasu M, Hashiguchi S, Uematsu E, Fukai R, Tanaka K, Tada M, Joki H, Takahashi T, Koyano S, Doi H, Takeuchi H, Tanaka F.

Mov Disord Clin Pract. 2018 Apr 6;5(3):333-336. doi: 10.1002/mdc3.12614. eCollection 2018 May-Jun.

Moyamoya Disease Presenting as Alternating Hemiparesis with Relapsing Remitting Hemichorea: An Unusual Manifestation

Maheshwari S, Anthony A, Kushwaha S, Singh S, Desai R, Madan D.

J Pediatr Neurosci. 2018 Oct-Dec;13(4):514-516. doi: 10.4103/JPN.JPN_85_18.

Calcium Signaling, PKC Gamma, IP3R1 and CAR8 Link Spinocerebellar Ataxias and Purkinje Cell Dendritic Development

Shimobayashi E, Kapfhammer JP.

Curr Neuropharmacol. 2018 Jan 30;16(2):151-159. doi: 10.2174/1570159X15666170529104000.

Novel De Novo KCND3 Mutation in a Japanese Patient with Intellectual Disability, Cerebellar Ataxia, Myoclonus, and Dystonia

Kurihara M, Ishiura H, Sasaki T, Otsuka J, Hayashi T, Terao Y, Matsukawa T, Mitsui J, Kaneko J, Nishiyama K, Doi K, Yoshimura J, Morishita S, Shimizu J, Tsuji S.

Cerebellum. 2018 Apr;17(2):237-242. doi: 10.1007/s12311-017-0883-4.

New targeted therapies and diagnostic methods for iron overload diseases

Kolnagou A, Kontoghiorghe CN, Kontoghiorghes GJ.

Front Biosci (Schol Ed). 2018 Jan 1;10(1):1-20. doi: 10.2741/s498.

Epidemiology of Cerebellar Diseases and Therapeutic Approaches

Salman MS.

Cerebellum. 2018 Feb;17(1):4-11. doi: 10.1007/s12311-017-0885-2.

The Visual Agnosias and Related Disorders

Haque S, Vaphiades MS, Lueck CJ.

J Neuroophthalmol. 2018 Sep;38(3):379-392. doi: 10.1097/WNO.0000000000000556.

Selective Patterns of Cognitive Impairment in Spinocerebellar Ataxia Type 6 and Idiopathic Late-Onset Cerebellar Ataxia

Rentiya ZS, Jung BC, Bae J, Liszewski CM, Fishman A, Du AX, Margolis RL, Ying SH.

Arch Clin Neuropsychol. 2018 Jun 1;33(4):427-436. doi: 10.1093/arclin/acx077.

A Callosal Catastrophe: Toxic Leukoencephalopathy Associated with Thermogenic Weight Loss Supplement Use

Mahdavi ZK, Narayan R, Mainali S, Greenberg BM, Aiyagari V, McDonagh DL.

Neurocrit Care. 2018 Dec;29(3):504-507. doi: 10.1007/s12028-017-0473-9.

Movement disorders with neuronal antibodies: syndromic approach, genetic parallels and pathophysiology

Balint B, Vincent A, Meinck HM, Irani SR, Bhatia KP.

Brain. 2018 Jan 1;141(1):13-36. doi: 10.1093/brain/awx189.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias